Bank of America
SANA icon

Bank of America’s Sana Biotechnology SANA Stock Holding History

Bank of America’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$983K – 8350
2021
Q2 		$983K Buy
+50,000
New +$1.13M ﹤0.01% 4923

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Bank of America's SANA Position: Q1 2026 in Review

Bank of America increased its Sana Biotechnology (SANA) stake by 148% in Q1 2026, buying an estimated $6.93M and bringing the position to 2,946,861 shares worth $8.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3090.

Bank of America first reported a position in SANA in Q1 2021 and has held it in 21 quarters since. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Bank of America held 2,946,861 shares of Sana Biotechnology worth $8.49M as of Q1 2026.
  • Bank of America bought 1,760,610 Sana Biotechnology shares in Q1 2026, an estimated $6.93M.
  • Sana Biotechnology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3090 holding.
  • Bank of America first reported a position in Sana Biotechnology in Q1 2021 and has held it in 21 quarters since.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.